Mutation and expression analysis of the p73 gene in prostate cancer

Akira Yokomizo, Ming Mai, David G. Bostwick, Donald J. Tindall, Junqi Qian, Liang Cheng, Robert B. Jenkins, David I. Smith, Wanguo Liu

研究成果: ジャーナルへの寄稿学術誌査読

35 被引用数 (Scopus)

抄録

BACKGROUND. p53 is the most highly mutated tumor suppressor gene in human cancers. Recently, p73, a first homologue of p53, was identified and considered to be an imprinted tumor suppressor gene. Thus, we analyzed the possible role of p73 in human prostate cancers. METHODS. We investigated the expression levels and expressed allelotypes and searched for mutations in the p73 gene in 27 primary prostate cancers with matched normal tissues as well as in four prostate cell lines. RESULTS. Allelic expression analysis using polymorphisms in exons 2 and 5 revealed that p73 is biallelically expressed in both normal and tumor tissues, suggesting that p73 is not imprinted in prostate tissues. Quantitative PCR demonstrated that p73 expression is the same in both normal and tumor prostate tissues. Denaturing high-performance liquid chromatography and DNA sequencing revealed that there were no tumor- specific mutations in the p73 gene at the genomic level. CONCLUSIONS. These data indicate that alterations of p73, including mutations, changes in message abundance, and changes in allelic expression, are likely to be rare in early-stage prostate cancer, and that p73 could be a tissue-specific imprinting gene.

本文言語英語
ページ(範囲)94-100
ページ数7
ジャーナルProstate
39
2
DOI
出版ステータス出版済み - 4月 1 1999
外部発表はい

!!!All Science Journal Classification (ASJC) codes

  • 腫瘍学
  • 泌尿器学

フィンガープリント

「Mutation and expression analysis of the p73 gene in prostate cancer」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル